Codice QR

Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience

Purpose: To characterize our experience and the disease control and toxicity of proton therapy (PT) for patients with head and neck cancer (HNC). Patients and Methods: Clinical outcomes for patients with HNC treated with PT at our institution were prospectively collected in 2 institutional review bo...

Descrizione completa

Salvato in:
Autori principali: G. Brandon Gunn, MD, Adam S. Garden, MD, Rong Ye, MSc, Noveen Ausat, BA, Kristina R. Dahlstrom, PhD, William H. Morrison, MD, C. David Fuller, MD, PhD, Jack Phan, MD, PhD, Jay P. Reddy, MD, PhD, Shalin J. Shah, MD, Lauren L. Mayo, MD, Stephen G. Chun, MD, Gregory M. Chronowski, MD, Amy C. Moreno, MD, Jeffery N. Myers, MD, PhD, Ehab Y. Hanna, MD, Bita Esmaeli, MD, Maura L. Gillison, MD, PhD, Renata Ferrarotto, MD, Katherine A. Hutcheson, PhD, Mark S. Chambers, DMD, MS, Lawrence E. Ginsberg, MD, Adel K. El-Naggar, MD, PhD, David I. Rosenthal, MD, Xiaorong Ronald Zhu, PhD, Steven J. Frank, MD
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2021-06-01
Serie:International Journal of Particle Therapy
Soggetti:
proton therapy
head and neck cancer
toxicity
survival
Accesso online:https://theijpt.org/doi/pdf/10.14338/IJPT-20-00065.1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi